- Home
- CGBD vs FNA Comparison
CGBD vs FNA Comparison
Compare CGBD & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGBD
- FNA
- Stock Information
- Founded
- CGBD 2012
- FNA 2010
- Country
- CGBD United States
- FNA United States
- Employees
- CGBD N/A
- FNA N/A
- Industry
- CGBD Finance: Consumer Services
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CGBD Finance
- FNA Health Care
- Exchange
- CGBD Nasdaq
- FNA Nasdaq
- Market Cap
- CGBD 853.5M
- FNA 910.9M
- IPO Year
- CGBD 2017
- FNA 2021
- Fundamental
- Price
- CGBD $16.18
- FNA $13.04
- Analyst Decision
- CGBD Sell
- FNA Buy
- Analyst Count
- CGBD 2
- FNA 7
- Target Price
- CGBD $17.00
- FNA $15.20
- AVG Volume (30 Days)
- CGBD 217.5K
- FNA 1.4M
- Earning Date
- CGBD 05-06-2025
- FNA 03-06-2025
- Dividend Yield
- CGBD 11.27%
- FNA N/A
- EPS Growth
- CGBD N/A
- FNA N/A
- EPS
- CGBD 1.58
- FNA N/A
- Revenue
- CGBD $232,590,000.00
- FNA $256,182,000.00
- Revenue This Year
- CGBD $6.33
- FNA $14.88
- Revenue Next Year
- CGBD $13.96
- FNA $13.92
- P/E Ratio
- CGBD $10.61
- FNA N/A
- Revenue Growth
- CGBD N/A
- FNA 18.39
- 52 Week Low
- CGBD $15.01
- FNA $4.65
- 52 Week High
- CGBD $18.74
- FNA $13.13
- Technical
- Relative Strength Index (RSI)
- CGBD 34.42
- FNA 65.27
- Support Level
- CGBD $16.47
- FNA $13.01
- Resistance Level
- CGBD $17.00
- FNA $13.06
- Average True Range (ATR)
- CGBD 0.28
- FNA 0.03
- MACD
- CGBD -0.02
- FNA -0.03
- Stochastic Oscillator
- CGBD 22.30
- FNA 50.00
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.